Lessons from the Pandemic: COVID-19 and Health-Pharma Investigations

During the COVID-19 pandemic, journalists worldwide were suddenly thrown into the public health beat, trying to make sense of competing claims, and a science that seemed to change by the day. A session at the GIJC21 walked reporters through the COVID-19 pandemic, offering tips on covering the drug development and approval processes, evaluating scientific studies, unearthing conflicts of interest, and exposing fraud and malpractice.

How Membership Saved Chile’s Investigative Newsroom CIPER

In a GIJC21 session on business models for investigative journalism, panelist Claudia Urquieta from Chile’s CIPER shared how the investigative outlet started a membership program from scratch, what it takes to make this model work, and how its partners saved CIPER from an uncertain future.